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Abstract: A novel polypeptide hydrogel has been synthe-
sized by crosslinking poly(L-glutamic acid) (PLG) with
poly(ethylene glycol) (PEG). The PLG-PEG hydrogel was
shown to be highly hydrophilic, and the extent of swelling
varied with pH, increasing at higher ionization of the PLG.
Aside from electrostatic effects, such as ion–ion repulsion
and internal ion osmotic pressure, circular dichroism studies
showed that swelling response to pH also is affected by
secondary structural attributes associated with the polypep-
tide backbone. Modification of the polypeptide by changing
its hydrophobicity and degree of ionization was an effective
method for altering the overall extent of pH-responsive
swelling. Rapid de-swelling (contraction) was observed
when the PLG-PEG hydrogel was transferred from high to
low pH buffer solution, and this swelling/de-swelling be-
havior was reversible over repeated cycles. Drug release
from swollen hydrogels was examined using the model pro-
tein lysozyme. Rapid de-swelling of the hydrogel was found
to be an effective means of facilitating lysozyme release. The
crosslinking of synthetic polypeptides with PEG appears to
be a highly versatile approach to the preparation of pH-
responsive biodegradable hydrogels. © 1999 John Wiley &
Sons, Inc. J Biomed Mater Res, 47, 595–602, 1999.
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sive swelling; polyglutamic acid; polyethylene glycol; cross-
linking; protein release
INTRODUCTION
Crosslinked hydrogel networks are being investi-
gated as drug delivery systems due to their potential
to control the transport and release of macromolecular
drugs such as peptides, proteins, and oligonucleo-
tides.1 Acrylate polymers often are used to prepare
ionic crosslinked hydrogels for these applications.2
Copolymer hydrogels containing hydroxyethyl meth-
acrylate (HEMA) and methacrylate acid (MAA) have
been characterized with respect to their swelling ki-
netics3 and drug release properties.4,5 Such cross-
linked ionic hydrogels, which contain weakly ioniz-
able acidic or basic groups, typically exhibit swelling
behavior that can vary with pH, ionic strength, and
buffer conditions.6 Factors contributing to the overall
swelling forces normally include the polymer–solvent
interaction parameter, electrostatic interactions, inter-
nal ion osmotic pressure, and the transport and distri-
bution of protons and ions through the hydrogel.7,8
While considerable effort has been made to synthe-
size and characterize acrylate-based ionic hydrogels,
these materials are not biologically degradable by ei-
ther hydrolytic or enzymatic mechanisms. As a result,
acrylate systems are limited in their potential as bio-
degradable drug-delivery platforms. To overcome this
liability, a variety of novel chemistries has been ex-
plored that incorporate biodegradability into the
crosslinked hydrogel network.9 For example, unsatu-
rated polyesters have been used to prepare cross-
linked beads, and the release of bovine serum albumin
from these beads was shown to be facilitated by hy-
drolysis and erosion of the polymer network.10 The
synthesis of hydrolytically degradable hydrogels also
has been attempted by crosslinking block copolymers
of poly(ethylene glycol) with either poly(lactic acid) or
poly(glycolic acid).11
Polymers containing naturally occurring mono-
mers, such as amino acids and saccharides, represent
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a broad category of potentially biodegradable materi-
als with chemistries amenable for crosslinking.9
Crosslinked dextran hydrogels susceptible to biodeg-
radation by the enzyme dextranase have been pre-
pared.12 Release of high molecular weight proteins
from these hydrogel networks was shown to be con-
trolled by enzymatic degradation of the polymer net-
work rather than by diffusion through the hydrogel.
Alternatively, crosslinked hyaluronic acid has been
prepared and evaluated as a possible biodegradable
drug delivery platform.13
Recently, crosslinked polypeptide hydrogels con-
taining collagen14 and gelatin15,16 have been synthe-
sized. Synthetic polypeptides also have received inter-
est because they possess a more regular arrangement
and a smaller diversity of amino acid residues than
those derived from natural proteins. Examples of such
synthetic polypeptide hydrogels include poly(hy-
droxyethyl-L-glutamate),17 poly(L-ornithine),18 poly-
(aspartic acid),19 poly(L-lysine),20 and poly(L-glutamic
acid).21
Previously we reported on the synthesis of a variety
of polypeptides and demonstrated that release of a
small hydrophobic drug from these polymers could be
regulated by varying the amino acid composition and
hydrophobicity of the polypeptide backbone.22 Re-
cently, we also demonstrated that polymers synthe-
sized by block copolymerization of polypeptides with
poly(ethylene glycol) (PEG) could yield a complete
release of entrapped macromolecular protein drugs.23
In this paper we report the synthesis of a novel pH-
responsive polypeptide hydrogel produced by cova-
lently crosslinking poly(L-glutamic acid) (PLG) with
poly(ethylene glycol) (PEG). The swelling/de-
swelling behavior of the PLG-PEG hydrogel, as well as
factors affecting these properties, has been character-
ized. In addition, the possibility of utilizing the de-
swelling property of the hydrogel to facilitate the re-




g-Benzyl-L-glutamic acid (BLG) was purchased from
Sigma Chemical Co. (St. Louis, Missouri). Anhydrous hy-
drogen bromide (HBr) was supplied by Matheson Gas. Di-
amino-terminated poly(ethylene glycol)s (diamino-PEG) of
different molecular weights (300, 1500, and 3400 daltons)
were purchased from Shearwater Polymers (Huntsville, Ala-
bama). They were converted to their hydrochloride salts by
adjusting their pH in solution to 4.0–4.5 using dilute hydro-
chloric acid and isolating the product by lyophilization. All
other chemicals and solvents were obtained from Aldrich
Chemical Company (Milwaukee, Wisconsin). Water was
distilled and deionized, and dimethylformamide (DMF) was
stored over sodium sulfate.
Polypeptide synthesis
Poly(g-benzyl-L-glutamic acid) (PBLG) was prepared
from the BLG N-carboxyanhydride according to the method
described previously.23 Debenzylation of PBLG was carried
out by dissolving 1.0 g of PBLG in 100 mL of anhydrous
benzene and then slowly bubbling HBr through the vigor-
ously stirred solution for 3–4 h. Precipitates of the partially
debenzylated polymer began to form after 12–18 h. Stirring
was continued until the desired extent of debenzylation was
achieved, as determined by NMR analysis. Complete deben-
zylation of PBLG to poly(L-glutamic acid) (PLG) required
approximately 48 h. The partially or fully debenzylated
polymer was washed extensively with fresh portions of ac-
etone, followed by thorough drying under vacuum over
phosphorus pentoxide.
Polypeptide characterization
NMR analysis was performed in deuterated dimethyl
sulfoxide. The extent of debenzylation was estimated by
comparing integrals for benzyl phenyl protons at 7.3 ppm (5
protons) to the acidic proton at 12.1 ppm (1 proton). Intrinsic
viscosity of PBLG was calculated from viscosity measure-
ments performed at 25°C in dichloroacetic acid using a Can-
non–Ubbelohde capillary viscometer. PBLG molecular
weights were estimated according to the Mark–Houwink
relationship described by Doty et al.24 In a similar fashion,
the molecular weight of PLG was estimated by viscosity
measurements in 0.2M of aqueous NaCl at pH 7.3, following
the method of Idelson and Blout.25
Hydrogel synthesis
Synthesis of the polypeptide hydrogel is illustrated in Fig-
ure 1. As shown, poly(L-glutamic acid) (PLG) and diamino-
PEG (PEG) were mixed in DMF and allowed to equilibrate
overnight to insure intimate blending and interpenetration
of the two polymers. Unless otherwise specified, hydrogels
were prepared using an acid:amine molar ratio of 5:1 and a
diamino-PEG having a molecular weight of 1500 daltons.
When partially debenzylated polypeptides were utilized,
the same acid:amine ratio was used except that the moles of
acid were replaced by the total moles of amino acid mono-
mers within the polypeptide. It has been reported in the
literature26 that at a total polymer concentration below
about 10% by weight, the PLG-PEG-PLG ternary system ex-
isted as an isotropic, homogeneous solution. When polymer
concentrations exceeded this limit, however, a mixed isotro-
pic–cholesteric suspension was observed. It should be
596 MARKLAND ET AL.
pointed out that in our studies all hydrogels were prepared
from the isotropic solution.
The peptide coupling agent 2-isobutoxy-1-isobutoxy-
carbonyl-1,2-dihydroquinoline, isobutyl 1,2-dihydro-2-iso-
butoxy-1-quinolinecarboxylate (IIDQ) was dissolved in a
small volume of DMF, which then was added to the blended
polymer solution. IIDQ was used at a 20% excess relative to
the moles of the amine groups of the diamino-PEG. The
selection of IIDQ over traditional coupling agents, such as
dicyclohexylcarbodiimide (DCCI) and carbonyldiimidazole
(CDI) was due to its comparatively slower activation and
coupling kinetics. The slower kinetics permitted sufficient
time for mixing the coupling agent into the polymer solution
and subsequent handling of the mixture.27
After a brief but thorough mixing and removal of en-
trapped air bubbles, the solution was placed in a suitable
mold. To form a cylindrical hydrogel platform, the solution
was drawn within a glass pipette with an inside diameter of
approximately 5.5 mm. To produce a thin-film hydrogel sys-
tem, however, the solution was placed on a glass plate sur-
rounded by a 30 mm diameter glass ring. After curing for at
least 48 h at room temperature, the crosslinked hydrogel
platforms were removed from their molds. The cylindrical
hydrogel was cut into individual systems of approximately
10 mm in length. All hydrogel platforms were washed ex-
tensively by soaking first in water for 24 h (to insure hydro-
lysis of excess coupling agent) and then in DMF for several
days. The washing cycle was repeated until a constant
weight was obtained in distilled water. After washing, the
hydrogel systems were dried in air (no vacuum) for a mini-
mum of 3 days, followed by a more rigorous drying under
vacuum until a constant weight was achieved.
Hydrogel swelling experiments
Swelling experiments were conducted by equilibrating the
selected dry hydrogel platform in buffer until a constant
weight was obtained. Phosphate buffer was used for pH
values of 3.0 and 7.4 whereas citrate buffer was used for pH
from 2.5 to 7.0. The total buffer concentration was main-
tained at 0.01M, and the total ionic strength (m) was adjusted
by addition of sodium chloride. The buffer solution was
replaced frequently throughout the swelling process to in-
sure complete equilibration at the desired pH. Typically a
complete equilibration was obtained within 1 week. The
equilibrium swelling ratio (SR) was calculated as the ratio of





whereas the solvent weight fraction within a hydrogel (ws)








where ms is the mass solvent absorbed in the hydrogel at any
time (t).
Circular dichroism
The dried hydrogel was swollen in buffer and ground to
a fine powder in liquid nitrogen using a ceramic mortar and
pestle. The ground hydrogel particles then were resus-
pended in an appropriate buffer (either 0.01M of phosphate
or citrate, depending on the pH) and was subjected to cir-
cular dichroism (CD) measurements. CD spectra were ob-
tained as the accumulated average of four scans collected at
20 nm/min using a 1-mm cell path length, 50-mdeg sensi-
tivity, 1-nm bandwidth, and a response time of 0.5 s. Spectra
were collected between 190 and 260 nm and were treated
with solvent subtraction and noise suppression.
Drug loading and release experiments
Lysozyme was selected as a model protein drug. The drug
was loaded into the hydrogel platform by a swelling-dif-
fusion method. Drug solutions of known concentrations
were prepared in 0.01M of phosphate buffer (pH 7.4) at low
ionic strength (m = 0.04M). A dried and weighed cylindrical
hydrogel platform then was placed in 20 mL of the drug
solution and allowed to swell for 4 days at 4°C under gentle
Figure 1. Scheme of the synthesis of the crosslinked poly-
peptide hydrogel.
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agitation. The swollen hydrogel system was removed,
wiped dry using a laboratory tissue, and weighed.
Release rate experiments were performed by placing the
swollen, drug-loaded hydrogel systems into vials containing
20.0 mL of 0.01M of phosphate buffer (pH 7.4) (m = 0.04M).
The vials were placed onto an oscillating shaker maintained
at 25°C and gently agitated. At selected time intervals, indi-
vidual hydrogel systems were removed from solution, gent-
ly wiped dry to remove excess buffer on the surface,
weighed, and then placed into new vials containing fresh
buffer solution. To examine the effect of volume change of
the hydrogel on drug release, selected swollen hydrogel sys-
tems were transferred into high ionic strength 0.01M phos-
phate buffer (pH 7.4) containing 0.9 wt. % sodium chloride
(m = 0.15M). The drug release studies then were performed
using the same procedures described above. Drug concen-
trations in the solutions were determined by UV absorbance
at 280 nm using a spectrophotometer.
The fractional change in swelling was calculated as the
ratio of the hydrogel mass at time t relative to the initial,
fully swollen mass determined immediately prior to the
start of release experiments. The results of drug release were
presented as the fraction of the drug dose remaining within





where mo is the total mass of drug loaded within the swollen
hydrogel at t = 0 and mt is the cumulative mass drug re-
leased at time t . It should be pointed out that the value of mo
was determined based on the final cumulative mass of drug
extracted from the hydrogel.
RESULTS AND DISCUSSION
Synthesis of PBLG was carried out using the BLG
N-carboxyanhydride in order to obtain polymers of
high molecular weights. Reprecipitation also was per-
formed in an attempt to remove low molecular weight
fractions. Viscosity measurements indicated that
PBLG debenzylation by HBr resulted in a loss of poly-
mer molecular weight; in one instance, a loss of ap-
proximately 25% was observed. This decrease in mo-
lecular weight was a result of polymer main-chain
degradation, as observed by other investigators.25
Typically, PLG polymers with molecular weights
above 100,000 daltons were obtained. Hydrogels were
prepared using these PLG polymers and the coupling
agent IIDQ according to the procedures described in
Figure 1.
Figure 2(a) shows that the equilibrium swelling ra-
tio (SR) of the PLG-PEG hydrogel increased as the pH
increased, mainly in the range of pH 4–6 where the
acidic moieties of PLG became increasingly ionized.28
In addition, the SR was influenced by the solvent ionic
strength; increasing ionic strength resulted in a reduc-
tion of the swelling ratio of the ionized hydrogel by
nearly 50%. Furthermore, polypeptide composition
was found to exert a significant impact on the swelling
characteristics of this hydrogel formulation. As seen in
Figure 2(a), the hydrogel prepared with a partially
debenzylated polypeptide containing only 40% free
L-glutamic acid residues yielded no appreciable
Figure 2. Equilibrium swelling of the polypeptide hydrogel as a function of pH. A hydrogel was synthesized using a
1500-Da diamino-PEG and an acid/amine loading ratio of 5. Swelling data were presented as (A) the equilibrium swelling
ratio and (B) the weight fraction solvent within the swollen hydrogel. Hydrogels containing the fully debenzylated PLG were
swollen at either low (d) (0.04M) or high (n) (0.15M) ionic strength whereas those containing a partially debenzylated PLG
(40% free acid moieties) were swollen at only low ionic strength (j) (0.04M). Error bars represent the standard deviation (n
= 3).
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change in swelling across the pH range and over the
time frame studied. Measurement of the solvent frac-
tion [Fig. 2(b)], however, indicated that this partially
debenzylated polypeptide hydrogel still contained
over 40% by weight of buffer. Hence, modification of
the hydrophobicity and ionic composition of the hy-
drogel appears to be a simple and yet useful strategy
for manipulating the pH-dependent swelling proper-
ties of the hydrogel system.
While swelling increased consistently with pH, an
obvious inflection in equilibrium SR was observed
at pH 5.0 under both low and high ionic strength con-
ditions [Fig. 2(a)]. If the pH-induced changes in swell-
ing were only a function of ionization, polymer relax-
ation, and swelling mechanisms, a smooth change in
swelling in response to pH would have been antici-
pated.8 The inflection seen in Figure 2(a) therefore
suggested that additional mechanisms might have
contributed to the pH-dependent swelling of these hy-
drogels.
The polymer PLG is known to undergo a helix-to-
coil transition within the pH range where the above
inflection was observed.28 In addition, the PLG-PEG
hydrogels also have been reported to possess orga-
nized structural attributes in the solid state.29 Our re-
sults from CD spectra (Fig. 3) show that hydrogels
maintained at pH # 4.5 exhibited a single minimum at
about 229 nm, implicating the presence of organized
beta structure within the polymer network.30 When
the pH was raised above pH 4.5, however, a single
maximum was seen near 218 nm, suggesting a pH-
induced relaxation towards the formation of a random
coil structure. Apparently protonation of the carboxyl
groups on the polypeptide at pH # 4.5 was able to
produce hydrogen bonding which stabilized the orga-
nized structural features observed in the CD spectra.
Similar to the helix-coil transition of free PLG in solu-
tion,28 ionization of the carboxyl groups at higher pH
(pH > 4.5) appears to destabilize these organized
structural features within the hydrogel, permitting re-
laxation of the polymer chains towards the random-
coil configuration.
The reversibility of the swelling/de-swelling behav-
ior was demonstrated by repeatedly cycling the PLG-
PEG hydrogel between buffers at pH 6.5 and pH 5.5
over a 24-h period. As shown in Figure 4, the hydrogel
rapidly contracted when placed in a pH 5.5 buffer but
slowly returned to nearly the original swollen volume
at pH 6.5 over the remainder of the 24-h period. This
process appeared to be completely reversible, as the
same swelling/de-swelling behavior continued across
several cycles. The hydrogel returned to its original
volume when allowed to swell to equilibrium at the
end of the experiment.
The swelling properties of the hydrogel appeared to
be influenced by the PLG concentration, PEG loading,
and PEG molecular weight. As shown in Figure 5(a),
crosslinking of the polypeptide using progressively
increased PLG concentrations produced ionized net-
works that exhibited an appreciably reduced degree of
swelling. This phenomenon is believed to be due to
the formation of a higher intermolecular crosslinking
density as the PLG concentration is increased. In con-
trast, swelling at pH 3.0 of the unionized hydrogel did
not show any appreciable dependence on the PLG
concentration. This finding suggests that swelling at
low pH is not significantly influenced by the crosslink-
Figure 3. Circular dichroism spectra of the PLG-PEG hy-
drogel suspension in buffer at various pH levels (ionic
strength of 0.1M). A hydrogel was synthesized using 1500
Da diamino-PEG at an acid/amine loading ratio of 5.
Figure 4. Reversible effect of pH on the swelling/de-
swelling behavior of the PLG-PEG hydrogel. Swollen hydro-
gels were placed in pH 5.5 buffer for 4 h and then placed
back into buffer at pH 6.5 for 19 h. Error bars represent the
standard deviation (n = 3).
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ing density but rather by other factors, such as hydro-
phobicity of the polymer or hydrogen bond interac-
tions.
Figure 5(b) shows that decreasing the molar ratio of
PEG within the formulation produced hydrogels with
a higher overall extent of swelling at high pH. Similar
trends in swelling were obtained as the molecular
weight of PEG was lowered [Fig. 5(c)]. These results
suggest that both the PEG loading and its molecular
weight are important factors in regulating the effective
crosslink density of the polypeptide hydrogel. It is not
surprising that higher PEG molecular weight pro-
duced greater crosslinking density since crosslinking
is performed in polymer solutions where PEG chains
having a larger hydrodynamic radius are more likely
to span between, and thereby crosslink, adjacent PLG
chains.
While both the loading and molecular weight of
PEG could influence swelling via changes to the
crosslinking density, they also could impart such ef-
fects via changes to the ratio of PEG to PLG in the
hydrogel. As the content of PEG is increased, a dilu-
tion of the electrostatic swelling forces within the hy-
drogel is produced as the relative concentration of the
acidic moieties within the hydrogel formulation is re-
duced. Consequently, the overall magnitude of the
ion–ion repulsion and internal ionic osmotic pressure
swelling forces is diminished and the overall degree of
swelling is reduced. Interestingly, swelling of the
unionized hydrogel at a low pH followed exactly the
opposite trend as that obtained at a high pH; that is,
formulations containing a higher PEG ratio produced
a higher degree of swelling [Fig. 5(b,c)]. Although the
mechanism contributing to such differences is not yet
clear, it is hypothesized that increasing the ratio of
PEG to PLG within the unionized hydrogel may in-
crease bulk hydrophilicity or provide steric shielding
to intermolecular hydrogen bonding, thereby result-
ing in the observed swelling trends.
The pH-dependent swelling/de-swelling properties
of an ionic hydrogel have been utilized in the delivery
of a variety of drugs, including insulin31–33 and other
macromolecules.34 To assess whether the de-swelling
property of the hydrogel could be employed as a
means of facilitating release of the entrapped drug, the
model protein lysozyme (molecular weight 16,000)
was loaded within the PLG-PEG hydrogel. Drug load-
ing was performed by swelling the hydrogel at a low
ionic strength (m = 0.04M), and drug release was moni-
tored while de-swelling the hydrogel at a high ionic
strength (m = 0.15M). As shown in Figure 6, the control
hydrogel systems that were not subject to changes in
swelling exhibited no appreciable release of lysozyme.
In sharp contrast, however, a rapid and extensive ly-
sozyme release was obtained once de-swelling of the
swollen hydrogels was initiated. Over a 2-h period, a
40% decrease in swelling accompanied by approxi-
mately a 50% release of the total entrapped dose of
lysozyme was observed. Further studies of regulating
the release rate of protein drugs from this PLG-PEG
hydrogel by manipulating the pH change in the re-
lease environment currently are underway in our
laboratory.
CONCLUSIONS
In summary, a novel amide-linked pH-responsive
polypeptide hydrogel containing PLG and diamino-
PEG was synthesized. Swelling of this PLG-PEG hy-
drogel was observed to vary significantly as the de-
gree of ionization along the polypeptide chain was
modified. This was accomplished via changes of the
external pH or by modifying the hydrophobicity of the
polypeptide. Secondary structural attributes were
shown to exist within the unionized PLG-PEG hydro-
gel, presumably the result of hydrogen bond forma-
Figure 5. Effects of variables on the swelling characteristics of the PLG-PEG hydrogel at pH 3.0 (j) and pH 7.4 (M). Studies
were performed by varying (A) PLG concentration, (B) the acid:amine crosslinking ratio (refer to description in the Materials
and Methods section), and (C) PEG molecular weight during hydrogel synthesis. Buffer solutions were prepared at low ionic
strength (0.04M).
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tion between the PLG residues or between the acid
moieties of the PLG and the oxygen atoms on the PEG
crosslinker. Variables involved during the synthesis of
the PLG-PEG hydrogel, such as the PLA concentra-
tion, PEG loading, and molecular weight of the PEG,
were found to influence significantly the swelling
properties of the polypeptide hydrogel. For the highly
swollen and ionized gel, the extent of swelling was
dependent on factors affecting the density of cross-
linking obtained during synthesis. For the unionized
hydrogel, however, swelling appeared to be influ-
enced by factors affecting the bulk hydrophilicity of
the polymer network. The rapid contraction of the
PLG-PEG hydrogel in response to external conditions
was found to be an effective means for facilitating
release of the entrapped protein lysozyme. Overall,
the use of polypeptides in the synthesis of hydrophilic
hydrogels appears to be a highly versatile and effec-
tive approach for producing biodegradable drug de-
livery systems.
We thank Amy Miles for technical assistance.
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